Related Experiment Video
Updated: Jan 10, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Improved Lung Function With Cyclophosphamide and Rituximab in a Case of Shrinking Lung Syndrome
Shiza Chaudhry1, Haider Bokhary2, Mark Quinn3
1Internal Medicine, York and Scarborough Teaching Hospitals NHS Foundation Trust, York, GBR.
Shrinking lung syndrome (SLS), a rare autoimmune disease complication, presents with shortness of breath and chest pain. Early diagnosis and treatment of SLS can lead to significant lung function recovery.
Area of Science:
- Pulmonology
- Rheumatology
- Internal Medicine
Background:
- Shrinking lung syndrome (SLS) is a rare respiratory condition linked to systemic autoimmune diseases.
- Systemic lupus erythematosus (SLE) is the most common associated condition, often making diagnosis challenging.
- SLS is characterized by reduced lung volumes and restrictive physiology without interstitial lung disease.
More Related Videos
09:02Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Pneumothorax-II
Clinical Manifestations:
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Cycle: Exhalation